TECX
NASDAQ · Biotechnology
Tectonic Therapeutic Inc
$29.06
+1.09 (+3.90%)
Open$28.06
Previous Close$27.97
Day High$29.27
Day Low$27.33
52W High$36.03
52W Low$14.39
Volume—
Avg Volume182.5K
Market Cap544.52M
P/E Ratio—
EPS$-4.04
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+28.1% upside
Current
$29.06
$29.06
Target
$37.23
$37.23
$31.47
$37.23 avg
$57.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 64.42M | 64.45M | 57.14M |
| Net Income | 9.98M | 8.55M | 7.27M |
| Profit Margin | 15.5% | 13.3% | 12.7% |
| EBITDA | 14.26M | 12.01M | 10.46M |
| Free Cash Flow | 6.92M | 8.94M | 6.74M |
| Rev Growth | +22.9% | -2.6% | -4.3% |
| Debt/Equity | 0.17 | 0.17 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |